Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 5
2010 5
2011 5
2012 6
2013 10
2014 12
2015 8
2016 7
2017 9
2018 6
2019 13
2020 17
2021 11
2022 12
2023 16
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual participant data meta-analysis.
Gunasekera KS, Marcy O, Muñoz J, Lopez-Varela E, Sekadde MP, Franke MF, Bonnet M, Ahmed S, Amanullah F, Anwar A, Augusto O, Aurilio RB, Banu S, Batool I, Brands A, Cain KP, Carratalá-Castro L, Caws M, Click ES, Cranmer LM, García-Basteiro AL, Hesseling AC, Huynh J, Kabir S, Lecca L, Mandalakas A, Mavhunga F, Myint AA, Myo K, Nampijja D, Nicol MP, Orikiriza P, Palmer M, Sant'Anna CC, Siddiqui SA, Smith JP, Song R, Thuong Thuong NT, Ung V, van der Zalm MM, Verkuijl S, Viney K, Walters EG, Warren JL, Zar HJ, Marais BJ, Graham SM, Debray TPA, Cohen T, Seddon JA. Gunasekera KS, et al. Among authors: franke mf. Lancet Child Adolesc Health. 2023 May;7(5):336-346. doi: 10.1016/S2352-4642(23)00004-4. Epub 2023 Mar 13. Lancet Child Adolesc Health. 2023. PMID: 36924781 Free PMC article.
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Trevisi L, Hernán MA, Mitnick CD, Khan U, Seung KJ, Rich ML, Bastard M, Huerga H, Melikyan N, Atwood SA, Avaliani Z, Llanos F, Manzur-Ul-Alam M, Zarli K, Binegdie AB, Adnan S, Melikyan A, Gelin A, Isani AK, Vetushko D, Daugarina Z, Nkundanyirazo P, Putri FA, Vilbrun C, Khan M, Hewison C, Khan PY, Franke MF. Trevisi L, et al. Among authors: franke mf. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1525-1532. doi: 10.1164/rccm.202211-2125OC. Am J Respir Crit Care Med. 2023. PMID: 36802336 Free PMC article. Clinical Trial.
Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017.
Matias WR, Guillaume Y, Augustin GC, Vissieres K, Ternier R, Charles RC, Harris JB, Franke MF, Ivers LC. Matias WR, et al. Among authors: franke mf. Emerg Infect Dis. 2023 Sep;29(9):1929-1932. doi: 10.3201/eid2909.230401. Emerg Infect Dis. 2023. PMID: 37610182 Free PMC article.
Interventions to increase the uptake and continuation of pre-exposure prophylaxis (PrEP) by adolescent girls and young women at high risk of HIV in low-income and middle-income countries: a scoping review.
Ekwunife OI, Ejie IL, Okelu V, Mita C, Durosinmi-Eti O, Powell A, Franke MF. Ekwunife OI, et al. Among authors: franke mf. BMJ Glob Health. 2022 Dec;7(12):e009474. doi: 10.1136/bmjgh-2022-009474. BMJ Glob Health. 2022. PMID: 36593640 Free PMC article. Review.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Lotia Farrukh I, Lachenal N, Adenov MM, Ahmed S, Algozhin Y, Coutisson S, Garavito ES, Hewison C, Holtzman D, Huerga H, Janmohamed A, Khan PY, Jacques GL, Lomtadze N, Melikyan N, Mitnick CD, Mussabekova G, Osso E, Perea S, Putri FA, Rashidov M, Rich ML, Sakhabutdinova Y, Seung KJ, Stambekova A, Vásquez DV, Franke MF, Khan U. Lotia Farrukh I, et al. Among authors: franke mf. Clin Infect Dis. 2024 Jan 25;78(1):144-148. doi: 10.1093/cid/ciad445. Clin Infect Dis. 2024. PMID: 37606512 Free PMC article.
Value of observational data for multidrug-resistant tuberculosis.
Rodriguez CA, Mitnick CD, Franke MF. Rodriguez CA, et al. Among authors: franke mf. Lancet Infect Dis. 2019 Sep;19(9):930-931. doi: 10.1016/S1473-3099(19)30424-4. Lancet Infect Dis. 2019. PMID: 31478514 No abstract available.
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.
Rich ML, Khan U, Zeng C, LaHood A, Franke MF, Atwood S, Bastard M, Burhan E, Danielyan N, Dzhazibekova PM, Gadissa D, Ghafoor A, Hewison C, Islam MS, Kazmi E, Khan PY, Lecca L, Maama LB, Melikyan N, Naing YY, Philippe K, Saki NA, Seung KJ, Skrahina A, Tefera GB, Varaine F, Vilbrun SC, Võ L, Mitnick CD, Huerga H. Rich ML, et al. Among authors: franke mf. Int J Tuberc Lung Dis. 2023 Jun 1;27(6):451-457. doi: 10.5588/ijtld.22.0613. Int J Tuberc Lung Dis. 2023. PMID: 37231598 Free PMC article.
Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB.
Zeng C, Mitnick CD, Hewison C, Bastard M, Khan P, Seung KJ, Rich ML, Atwood S, Melikyan N, Morchiladze N, Khachatryan N, Khmyz M, Restrepo CG, Salahuddin N, Kazmi E, Dahri AA, Ahmed S, Varaine F, Vilbrun SC, Oyewusi L, Gelin A, Tintaya K, Yeraliyeva LT, Hamid S, Khan U, Huerga H, Franke MF. Zeng C, et al. Among authors: franke mf. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):34-40. doi: 10.5588/ijtld.22.0324. Int J Tuberc Lung Dis. 2023. PMID: 36853128 Free PMC article.
Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho.
Oyewusi L, Zeng C, Seung KJ, Mpinda S, Kunda M, Mitnick CD, Kanu M, Tamirat M, Makaka J, Mofolo M, Maime R, Maama L, Senyo N, Oguntoyinbo B, Mayombo L, Franke MF. Oyewusi L, et al. Among authors: franke mf. Glob Health Action. 2024 Dec 31;17(1):2305930. doi: 10.1080/16549716.2024.2305930. Epub 2024 Feb 2. Glob Health Action. 2024. PMID: 38305025 Free PMC article.
135 results